• KOREAN
  • English

ROPHIBIO

ROPHIBIO

Primary Menu

Skip to content
  • About
    • About ROPHIBIO
    • History
    • Executives
    • Organization
    • Location
  • Technology
    • Synthetic Promoter Technology
    • Genetically Engineered CHO Cell Technology
    • Cell Line Development and Cell Analysis Technologies
    • Stem Cell Therapy
  • Pipelines
    • Biotherapeutic Pipelines
    • Biosimilar Drug Candidates
  • Notice
  • Menu

Notice

Home > 뉴스/공지사항 > News

News

No Title Author Date Views
1
Announcement for Stock Split and Share Transfer
rafagen 2019.08.01 2570
  • 1

뉴스/공지사항

  • Notice
  • Menu
Korea Office
301, 194-41, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu,
Cheongju-si, Chungcheongbuk-do, Korea
T: +82-43-239-0080 | F: +82-303-0956-0080 | Email: info@rophibio.com
US Office
615 S Frederick Ave, Suite 302B Gaithersburg, MD 20877
TEL : 301-309-1601